TrialDepression and anxiety2021

Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.

Nithya Ramakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.